Department of Quantitative Sciences, GlaxoSmithKline (GSK), Research Triangle Park, NC 27709, USA.
Science. 2012 Jul 6;337(6090):100-4. doi: 10.1126/science.1217876. Epub 2012 May 17.
Rare genetic variants contribute to complex disease risk; however, the abundance of rare variants in human populations remains unknown. We explored this spectrum of variation by sequencing 202 genes encoding drug targets in 14,002 individuals. We find rare variants are abundant (1 every 17 bases) and geographically localized, so that even with large sample sizes, rare variant catalogs will be largely incomplete. We used the observed patterns of variation to estimate population growth parameters, the proportion of variants in a given frequency class that are putatively deleterious, and mutation rates for each gene. We conclude that because of rapid population growth and weak purifying selection, human populations harbor an abundance of rare variants, many of which are deleterious and have relevance to understanding disease risk.
罕见的遗传变异与复杂疾病风险有关;然而,人类群体中罕见变异的丰富程度仍不清楚。我们通过对 14002 个人的 202 个编码药物靶点的基因进行测序来探索这一变异范围。我们发现罕见变异非常丰富(每 17 个碱基就有一个),而且具有地域局限性,因此,即使样本量很大,罕见变异目录也将在很大程度上不完整。我们利用观察到的变异模式来估计人口增长参数、给定频率类别的变异中假定有害的比例以及每个基因的突变率。我们的结论是,由于人口的快速增长和较弱的净化选择,人类群体中存在大量的罕见变异,其中许多是有害的,与理解疾病风险有关。